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LILBID MSThe AcrA/AcrB/TolC complex is responsible for intrinsic multidrug resistance (MDR) in Escherichia coli.
Together with the periplasmic adaptor protein AcrA and the outer membrane channel TolC, the inner
membrane component AcrB forms an efﬂux complex that spans both the inner and outer membrane and
bridges the periplasm of the Gram-negative cell. Within the entire tripartite complex, homotrimeric AcrB
plays a central role in energy transduction and substrate selection. In vitro selected designed ankyrin repeat
proteins (DARPin) that speciﬁcally bind to the periplasmic domain of AcrB were shown to ameliorate
diffraction resolution of AcrB/DARPin protein co-crystals (G. Sennhauser, P. Amstutz, C. Briand, O.
Storchenegger, M.G. Grutter, Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors,
PLoS Biol 5 (2007) e7). Structural analysis by X-ray crystallography revealed that 2 DARPin molecules were
bound to the trimeric AcrB wildtype protein in the crystal, whereas the V612F and G616N AcrB variant crystal
structures show 3 DARPin molecules bound to the trimer. These speciﬁc stoichiometric differences were
analyzed in solution via densitometry after microchannel electrophoresis, analytical ultracentrifugation and
via laser-induced liquid bead ion desorption mass spectrometry (LILBID-MS). Using the latter technology, we
investigated the gradual disassembly of the AcrB trimer and bound DARPin ligands in dependence on laser
intensity in solution. At low laser intensity, the release of the detergent molecule micelle from the AcrB/
DARPin complex was observed. By increasing laser intensity, dimeric and monomeric AcrB species with
bound DARPin molecules were detected showing the high afﬁnity binding of DARPin to monomeric AcrB
species. High laser intensity LILBID MS experiments indicated a spectral shift of the monomeric AcrB peak of
3.1 kDa, representing a lowmolecular weight ligand in all detergent-solubilized AcrB samples and in the AcrB
crystal. The identity of this ligand was further investigated using phospholipid analysis of puriﬁed AcrB and
AcrB variant samples, and indicated the presence of phosphatidylethanolamine and possibly cardiolipin, both
constituents of the Escherichia coli membrane.9424, Fax: +49 69 798 29560.
51, Fax: +49 69 798 29201.
(B. Brutschy),
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Tripartite complexes are important toxic compound resistance
determinants in Gram-negative bacteria. These complexes are
composed of an energy transducing pump, residing in the inner
membrane, a channel in the outer membrane and a periplasmic
adapter protein that establishes a stable connection between the
inner-membrane pump and the outer-membrane channel. In oppor-
tunistic pathogens like Escherichia coli and Pseudomonas aeruginosa,the multidrug resistance (MDR) pumps AcrAB-TolC and MexAB-
OprM, respectively, are responsible for resistance phenotypes against
a great variety of different antimicrobial agents. AcrB and MexB
represent the inner-membrane located pump in these complexes and
belong to the large superfamily of Resistance Nodulation and cell
Division (RND) transport proteins. These homologous proteins
have been studied in detail on the functional [1–6] and structural
level [7–10]. AcrA and MexA act as adapter proteins and stabilize
binding of AcrB and MexB to TolC and OprM, respectively [11].
Initial crystallographic data from AcrB protein crystals provided
substantial structural insights and presented the protein as a
homotrimer [12], in which all of the monomers adopt the same
conformation. Later, trimerization was postulated to be the physical
basis for a conformational cycling mechanism for drug efﬂux, on basis
of recent crystal structures of asymmetric AcrB, which suggested that
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tight (T) and open (O) [6–9]. Moreover, trimerization was also
observed in the crystal structure of the AcrB homolog MexB from
P. aeruginosa [10] and the CusA silver- and copper ion RND efﬂux
protein [13]. Biochemical experiments with covalently linked AcrB
monomers indicated that trimerization of AcrB is essential for its
function and that inactivation of one monomer is sufﬁcient to block
the activity of the entire AcrAB-TolC complex [14]. Analytical ultracen-
trifugation provided evidence that AcrB is most likely trimeric in its
detergent solubilized state aswell [9,15]. Thus, trimerization is believed
a general feature of proteins of the RND superfamily.
Designed ankyrin repeat proteins (DARPins) represent a novel
antibody-like scaffold that is based on a consensus design of the
ankyrin repeat motif [16]. In nature, the fundamental function of
ankyrin repeat proteins is the establishment of speciﬁc protein–
protein interactions [17]. Highly speciﬁc DARPins have been raised
against a number of target protein using in vitro selection methods
such as ribosome display [18] and phage display [19]. Selected high
afﬁnity binders have been used in co-crystallization experiments [20]
and with AcrB, the ﬁrst example of crystals for a membrane protein in
complex with DARPins was obtained [9]. In the AcrB/DARPin co‐
crystal structure, two DARPins are bound to the periplasmic domain of
the AcrB trimer. A single DARPin molecule binds to the surface of
the loose (L) and tight (T) conformers each, but not to the open (O)
conformer.
We address in this manuscript the interaction of DARPins with
different variants of AcrB. During our X-ray crystallographic analysis
of the AcrB/DARpin complexes we observed different stoichiometries
and wondered if the protein/DARPin complex behaves similarly in
solution. The method applied was laser-induced liquid bead ion
desorption mass spectrometry (LILBID MS), which is a novel, native
mass spectrometry, that allows detection of membrane protein
complexes in a detergent-solubilized state. Depending on the laser
intensity, entire protein complexes or contributing subunits can be
observed [21–24]. Nano-ESI has also been applied to analyze
membrane proteins [25], but the analysis of the spectra might be a
challenge due to the highly charged ions and overlapping ion series,
which might be solved by MS/MS and ion-chromatography. Apart
from the stoichiometries, LILBID-MS gives us also insight in the
stability of the DARPin/AcrB interaction, as well as the interactions
(i.e. most likely the loop structure) of the monomers forming an AcrB
trimer. Here, we analyze three different AcrB variants in detergent-
solubilized and crystalline state, with and without bound DARPin
molecules.
2. Materials and methods
2.1. Construction of the AcrB mutants AcrB_dl, AcrB_V612F and
AcrB_G616N
AcrB variants (AcrB_dl, AcrB_V612F and AcrB_G616N) were
constructed by site-directed mutagenesis using the Quikchange
protocol from Stratagene. In the AcrB_dl (deleted loop) mutant
amino acids 218–239 (QLGGTPPVKGQQLNASIIAQTR) were removed.
Amino acid substitution and region deletion were achieved with 5′
phosphorylated primers. Cloning procedures were performed on the
pET24 vector carrying the wildtype acrB gene as template
(pET24acrBHis, [26]). The ﬁnal constructs were veriﬁed by sequencing
(Microsynth, Switzerland).
2.2. Drug susceptibility assay
E. coli BW25113 ΔacrB carrying pET24acrBHis (AcrB wt),
pET24acrB_dlHis (AcrB_dl) and pET24 (empty vector) were used for
minimal inhibitory concentration (MIC) experiments as described
earlier [3].2.3. Protein expression and puriﬁcation
Overexpression and membrane preparation of AcrB wt, AcrB_
V612F, AcrB_dl and AcrB_G616N was carried out as previously
described [7] with modiﬁcations. During solubilization and puriﬁca-
tion only the detergent n-dodecyl-β-maltoside (DDM, Mw 510.9,
GLYCON Biochemicals GmbH, Luckenwalde, Germany) was used
throughout the procedure. Membranes were solubilized in 20 mM
Tris/Cl, 150 mMNaCl, 10 mM imidazole, 10% glycerol and 2% DDM, pH
7.5 (15–20 ml total volume). The detergent-solubilized fraction was
separated from insoluble material by centrifugation at 145000×g at
4 °C for 1 h and was subsequently applied to a Ni2+-nitrilotriacetic
acid (NTA)-agarose column (2 ml bed volume, Qiagen) pre-equili-
brated with 20 column volumes (CV) of buffer 1 (20 mM Tris/Cl,
150 mM NaCl, 10 mM imidazole, 10% glycerol and 0.03% DDM, pH
7.5). The column was washed with 45 CV buffer 1 and subsequently
washed with 30 CV buffer 2 (20 mM Tris/Cl, 150 mM NaCl, 50 mM
imidazole, 10% glycerol and 0.03% DDM, pH 7.5). AcrB was eluted in
6 ml of buffer 3 (20 mMTris/Cl, 150 mMNaCl, 200 mM imidazole, 10%
glycerol and 0.03% DDM, pH 7.5). Puriﬁed DARPins (inhibitor 1108_19
[9]) were added to the puriﬁed AcrB in a two-fold molar excess (to
AcrB monomer). After concentration in centrifugal ﬁlter devices with
a cutoff size of 100 kDa (Amicon Ultra, Millipore), AcrB/DARPin
protein mixture (0.7 ml) was subjected to size exclusion chromatog-
raphy in buffer 4 (20 mM Tris/Cl, 150 mM NaCl, 0.03% DDM, pH 7.5)
using a GE Superdex 200 10/300GL column connected to a GE
Healthcare ÄKTAprime system. Peak fractions corresponding to AcrB
(trimer)/DARPin complexes were collected and concentrated in
centrifugal ﬁlter devices with a cutoff size of 100 kDa (Amicon Ultra,
Millipore) to 10 mg ml−1. For the gel ﬁltration run shown in Fig. 2,
AcrB and AcrB_dl were puriﬁed as above, but with 0.05% cyclohexyl-
hexylmaltoside as detergent. Subsequent size-exclusion chromatog-
raphy was performed using a GE HiLoad 16/60 Superdex 200 (120 ml
pack size) with 10 mM Na-HEPES, pH 7.0, 200 mM NaCl, and 0.05%
cyclohexyl-hexylmaltoside as running buffer at 0.4 ml min−1.
Apparent molecular weight values were calculated on basis of a run
under identical conditions with 4marker proteins (Ferritin (440 kDa),
Albumin (67 kDa), Ovalbumin (43 kDa), Ribonuclease A (13.7 kDa)).
Protein concentration was determined using the absorption at 280 nm
(Nanodrop ND-1000 spectrophotometer) or using the colorimetric
BCA protein determination method (Pierce).
2.4. LILBID MS
Before subjecting the samples to LILBID MS, a buffer exchange was
carried out on puriﬁed AcrB wt, AcrB variants and the AcrB/DARPin
complexes into 30 mM NH4HCO3, pH 7, 0.05% DDM. AcrB/DARPin co-
crystals were dissolved in 20 mM Tris/Cl, pH 7.5 containing 0.05%
DDM. Insoluble particles were removed by ﬁltration through a Millex-
GV syringe-driven ﬁlter unit (0.22 μm, Millipore). The ﬁnal protein
concentration was 10 μM with respect to the AcrB monomer.
Details of the experimental set-up for LILBID have been published
previously [27]. Micro-droplets of sample solution (diameter: 50 μm)
are produced at 10 Hz by a Piezo-driven droplet generator and
introduced into vacuum via differential pumping stages. There the
droplets are irradiated one by one by synchronized high-power mid-
infrared laser pulses. These are generated in a home-built optical
parametric oscillator using LiNbO3 crystals and a neodymium-doped
yttrium aluminium garnet and an Nd-YAG laser as pump. The
wavelength of the idler component of the radiation of the optical
parametric oscillator (OPO) is tuned to the absorption maximum of
water at around 3 μm corresponding to an excitation of the stretching
vibrations of water. At threshold intensity the droplet explodes
resulting in the emission of ions from liquid into vacuum. There the
ions are mass analyzed in a time-of-ﬂight reﬂectron mass spectrom-
eter. To detect very large biomolecules, a Daly type ion detector is
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intensity, LILBID desorbs ions out of the liquid very gently (ultrasoft
mode) enabling detection of the non-covalently assembled protein
complexes. At higher laser intensity (soft mode) the strong in-
teractions are still kept, the weak ones are broken. At the highest laser
intensities the complex is thermolyzed into its covalent subunits
(harsh mode). The signals from the detector are recorded by a
transient recorder. For data acquisition and analysis a user-written
labview program is used. The signal to noise ratio is improved by
subtracting an unstructured background, caused by metastable loss of
water and buffer molecules, from the original ion spectra. These
difference spectra are smoothed by averaging the signal over a pre-set
number of channels of the transient recorder.
2.5. Capillary electrophoresis
Protein samples (AcrB wt and AcrB_V612F) co-puriﬁed with
DARPins via SEC were analyzed on a 2100 Bioanalyzer (Agilent
Technologies Inc.) using the Agilent Protein 230 chips. Samples
(approx. 10 mg ml−1, 4 μl) were prepared according to the manual
with omission of the sample heating step. Relative concentrations of
AcrB and DARPin fractions were calculated from the integrals of the
eluted protein peak areas in the recorded electropherograms by the
software 2100 Expert (Agilent Technologies Inc.).
2.6. Phospholipid analysis via thin-layer chromatography
Phospholipid analysis of AcrB wt and AcrB_V612F samples was
done by thin-layer chromatography. Reference phospholipids (E. coli
polar lipids, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-
dioleoyl-sn-glycero-3-phosphate (DOPA), 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE), cardiolipin, (Avanti Polar Lipids, Inc.)
at 10–20 μg in CHCl3), DDM solution (1%), buffer (20 mM Tris,
150 mM NaCl, 0.03% DDM, pH 7.5) and puriﬁed protein (applied at
5×1 μl steps, 8.5 μg) in buffer were spotted onto a HPTC silica-gel 60
plate (Merck), which was pre-washed by migration with acetone in a
chromatography tank and air dried in a fume hood for several hours.
The plate was subsequently air-dried and the chromatography step
was performed in a chromatography tank with a mixture of CHCl3/
MeOH/H2O (65:25:4, v/v). Subsequently, the plate was dried for
30 min and phospholipids were stained with iodine (sublimating
iodine in a chromatography tank at room temperature). For
subsequent molybdate staining, the plate was initially heat dried at
160 °C to completely evaporate the iodine and sprayed with
molybdatophosphoric acid solution (Carl Roth) with subsequent
development at 160 °C.
2.7. Analytical ultracentrifugation
The molecular weight of AcrB wt and AcrB_V612F proteins in
complex with bound DARPins was estimated by sedimentation
velocity experiments. 400 μl of puriﬁed protein complexes (in
20 mM Tris/Cl, 150 mM NaCl, 0.03% DDM, pH 7.5) with an OD280 of
0.7 were applied to an An50-Ti analytical rotor (Beckman Coulter) in a
Beckman Proteome Lab XL-I centrifuge. Buffer was used as a reference
in sedimentation velocity experiments. Data were collected at
280 nm. Ultracentrifugation was performed at 40000 rpm at 4 °C.
Sedimentation velocities were analyzed with the software SEDFIT
[28].
3. Results and discussion
3.1. Oligomeric state of wt AcrB
Crystallographic and biochemical studies provided substantial
evidence for the characterized members of the RND superfamily to befunctional as a homotrimer [7–10,12–14,29]. The state of these
proteins in solution has recently been analyzed by analytical
ultracentrifugation [15] and suggests equilibrium between mono-
meric, dimeric, trimeric and higher oligomerization states of the AcrB
and CusA proteins. We selected the highly sensitive LILBID MS as
method of choice to determine the oligomeric state of AcrB
(theoretical Mw of His-tagged monomer: 114.6 kDa) in detergent
solution (Fig. 1). Under ultrasoft laser condition, the AcrB trimer
(charge state 2–6) is observed together with its detergent micelle,
causing a broad peak ranging from approximately m/z=190 to
m/z=225 with a ﬂat maximum at m/z=215 (Fig. 1E, the second
hump in Fig. 1C and 1D is assigned to an AcrB dimer in a micelle). This
corresponds to a size distribution of the micelles of 70 kDa and an
average size of 50 kDa. Approximately the same distribution is
observed for the (AcrB3+micelle)3− peak. With a molecular weight
of DDM of 510.9 Da this translates into an average aggregation
number of 98 and a maximal aggregation number of 140. The
correspondence with the values from the DDM provider is excellent.
With increasing laser intensity, the distribution shifted to detergent-
free trimeric AcrB (apparentMw: 355 kDa) (Fig. 1B–D). The estimated
detergent micelle from these experiments would be 70 kDa, close to
the size of a dodecylmaltoside detergent micelle in solution [30]. At
the highest laser intensity used, mainly monomeric AcrB (apparent
Mw: 116 kDa) was observed, but still a detectable amount of di- and
possibly trimeric AcrB were present in the sample (Fig. 1A). This
extraordinary stability appears to be quite unique compared with
other membrane protein complexes tested with LILBID MS [21,22,31].
The AcrB trimer contains an intermonomeric loop structure, protrud-
ing from one monomer to the neighboring monomer, which might be
the determinant for the observed stability of the trimeric complex.
Indeed, deletion of the loop resulted in the formation of mainly
monomeric AcrB (apparent Mw: 116 kDa) in detergent solution
(Fig. 2) and Escherichia coli harboring the deleted loop gene mutant
of AcrB (AcrB_dl) in aΔacrB background led to an increased sensitivity
towards drugs (Table 1). Notably, activity was not reduced complete-
ly, indicating that the role of the loop region could be an exclusive
structural one. Since the deleted loop variant of AcrB is still able to
form trimeric assemblies (Fig. 2, apparent Mw: 267 kDa), it appears
that trimerization is mandatory for the activity of AcrB, as has been
postulated based on biochemical and structural data [6–8,14]
3.2. DARPin binding to AcrB and AcrB variants
AcrB-speciﬁc DARPins were selected in vitro using ribosome
display, which facilitated the formation of well-diffracting (to 2.5 Å)
crystals of AcrB [9]. One AcrB trimer containing two bound DARPin
molecules was present in the asymmetric unit. This 3:2 (AcrB
monomer to DARPin) ratio was also found in detergent solution
using analytical ultracentrifugation [9].
Initial crystallographic studies of AcrB variants, which have
substitutions near the drug binding pocket located in the porter
domain of the periplasmic part of AcrB (i.e. V612F and G616N),
revealed cubic crystal forms (I23) with one AcrB monomer and one
DARPin molecule in the asymmetric unit (Eicher, Cha et al.,
unpublished). A symmetric setup would imply that DARPin/AcrB
trimer stoichiometry would have been shifted from 2 in the case of
wildtype AcrB to 3 in the case of the AcrB variants. To distinguish if the
different stoichiometries are only observed in crystalline state or can
also be detected in solution, we analyzed the samples using LILBID-
MS, capillary electrophoresis and analytical ultracentrifugation.
3.3. LILBID-MS of AcrB/DARPin complexes
For the AcrB wt/DARPin complex and the V612F/DARPin complex,
similar spectra were obtained under high intensity laser conditions
(Fig. 3) indicating that 2 or more DARPin molecules bind to the AcrB
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Fig. 1. Anion LILBID MS spectra of AcrBHis in detergent solution. The laser intensity decreases from the spectrum A (harsh) to the spectrum E (ultrasoft). At harsh laser intensity (A),
the charge distribution of themonomer (blue bars) is detected as themajor species in the spectrum but also a dimeric species (green bar) is observed. At soft laser intensity (B and C),
mainly AcrB trimers (red bars) are observed. At even softer laser intensity conditions (C to E), the trimeric species is shifting its mass distribution (((AcrB)3 micelle), gray), most
likely due to the presence of a detergent micelle on the AcrBHis trimer and displays a peak maxima corresponding to a charge distribution of a mass of 425 kDa.
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stoichiometry was determined to be 3 (Fig. 3), indicating a symmetric
AcrB:DARPin structural complex commensurate to the threefold
symmetry found in the AcrB_G616N crystals. Notably, Monroe et al.
[32] studied binding of different DARPin variants to AcrB via surface
plasmon resonance and showed that ﬂexible stoichiometries are
found indicating substantial plasticity of the AcrB/DARPin interaction.
The spectra of all three AcrB variants also revealed a broad peakwhichFig. 2. Size-exclusion chromatography elution proﬁles of puriﬁed wildtype AcrB (solid
line) and the deleted loop AcrB variant (AcrB_dl, dashed line) on a GE Superdex 200
10/300GL column coupled to a GE Healthcare ÄKTAprime FPLC system. The main peak
of the wildtype AcrB corresponds to AcrB trimers. In contrast, only a small fraction of
AcrB_dl elutes at comparable elution volume, whereas the majority of the protein
sample elutes later, indicating the presence of AcrB_dl monomers.might represent an AcrB monomer containing 2 bound DARPin
molecules, in contrast to what has been found in the crystal
structure [9]. This observation can be best explained by the formation
of DARPin dimers via a DARPin/DARPin interface and under ultrasoft
laser intensities 4 DARPin molecules are attached to both the AcrB wt
and V612F variant (Fig. 4A and B).When using dissolved AcrB/DARPin
crystals (space group P212121) for measurement with LILBID-MS
(Fig. 5), the only stoichiometry which could be detected was the one
observed in the crystal structure i.e. two DARPins bound per AcrB wt
trimer. Under ultrasoft laser intensities, the LILBIDMS spectrum of the
AcrB masses shifted to higher molecular weight species of 460 kDa,
representing the AcrB/DARPin complex of 380 kDa (2 DARPins per
AcrB trimer) and a detergent micelle of almost 80 kDa, comparable to
the difference in molecular weight found in the soluble AcrB
preparation (Fig. 1).
3.4. DARPins stoichiometry from capillary electrophoresis
Complex formation between AcrB wt and AcrB_V612F with
DARPin molecules was analyzed via co-elution using size-exclusion
chromatography and further investigation on AcrB/DARPinTable 1
Drug susceptibility of E. coli BW25113 ΔacrB expressing wt and mutant AcrB.a
Ery Oxa TPP+ Novo Cipro
AcrB wt 32-64 64 200-400 16-32 0.004-0.008
No AcrB 2 4 6.25 4 0.002
AcrB_dl 4 4 50 8 0.002
a Numbers indicate the minimal inhibitory concentration in μg ml-1. Abbreviations:
Ery=Erythromycin, Oxa=Oxacillin, TPP+=Tetraphenylphosphonium, Novo=Novo-
biocin, Cipro=Ciproﬂoxacin, AcrB wt=AcrB wildtype (pET24acrBHis), No AcrB=pET24
vector, AcrB_dl=AcrB with deleted loop (pET24acrB_dlHis).
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Fig. 3. Anion LILBID spectra of AcrB wt, AcrB_V612F variant and AcrB_G616N variant at harsh laser intensity. The panels A–C display identical spectra. The bars in the different blue
colors (panel A) represent charge distributions of the AcrB monomer with none (dark blue), one (violet) or two (turquoise) DARPins bound, the bars colored in the green range
(panel B) represent charge distribution of AcrB dimerswith none (dark green), one (blue-green) or two (grey-green) DARPins bound and the bars in the red colored spectrum (panel C)
represent charge distributions of the AcrB trimers with none (dark red), one (red), two (orange) or three (ochre) DARPins bound.
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capillary electrophoresis system 2100 Bioanalyzer. Electrophero-
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Fig. 4. Anion LILBID spectra of AcrB wt (A) and AcrB_V612F variant (B) at ultrasoft laser
intensity. The bars represent charge distribution of the AcrB trimer with no (dark-red),
1 (red), 2 (orange), 3 (ochre) or 4 (grey) DARPins bound. In panel B, the inset displays a
magniﬁcation of the boxed area.of the concentrations of AcrB and DARPins by integration of the
elution peak areas. Combined data from independent experiments
(n=5 and n=6 for AcrB wt and AcrB_V612F, respectively) clearly
show a signiﬁcant stoichiometric difference in DARPin binding
between the AcrB wt and the AcrB_V612F variant, indicating binding
of 2 DARPins to the AcrB wt trimer and binding of 3 DARPins in the
case of AcrB_V612F (Fig. 6). Whereas this data is in accordance to the
observations in the crystalline assembly of the AcrB wt/DARPins and
AcrB_V612F/DARPin complexes, it deviates from the LILBID measure-
ments where higher stoichiometries of AcrB/DARPin formations were
observed. However, the samples subjected to capillary electrophoresis
were used directly after elution from the gel ﬁltration column,
compared to the samples used for LILBID MS which were subjected to
buffer exchange and a concentration step, possibly favoring DARPin-
DARPin interaction.
3.5. Analytical UC of AcrB_V612F/DARPin complex
Solubilized AcrB_V612F (trimer fraction after SEC) and AcrB_
V612F/DARPin (after SEC) complexes were subjected to analytical
ultracentrifugation and sedimentation velocity analysis. A distinct
sedimentation velocity behavior between AcrB_V612F with and
without DARPins could be observed (Fig. 7). The calculated difference
in molecular weight of AcrB_V612F (373 kDa) and AcrB_V612F/
DARPin complex (427 kDa) could be attributed to the mass of three
DARPin molecules (theoretical molecular weight: 18.3 kDa). The
difference in molecular weight between AcrB wt without (374 kDa)
and DARPins bound complex (408 kDa) was explained by the binding
of two DARPin molecules per AcrB wt trimer [9].
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Fig. 5. Anion LILBID spectra of AcrB/DARPin complex from dissolved orthorhombic crystals. The laser intensity decreases from the spectrum A (harsh) to the spectrum E (ultrasoft).
The bars colored in the blue range (spectrum B) represent charge distributions of the AcrB monomer with none or one DARPin bound, the bars in the green range (spectrum B)
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The consistent observation of a double peak in all of the LILBID MS
spectra taken in the harsh mode (Figs. 3A and 5A) representing
masses 115.6 kDa and 118.7 kDa was interpreted as a result of a
stripping off (a) small molecule(s) with a (total) mass 3.1 kDa from
the AcrB monomer. This additional mass was also observed in the
spectra of dissolved AcrB crystals, but has not been observed in the
electron density derived from any of the wildtype or variant AcrB
crystal. However, AcrB wt, AcrB_V612F and their DARPin complexes
crystallize in the presence of DDM (Mw 511 Da). In the AcrB wt/DARPinFig. 6. The molar ratio of DARPins per AcrB trimer (ordinate) is plotted for wildtype
AcrB and AcrB_V612F (indicated on the abscissa). The mean ratios are 2.26 (white bar)
and 2.83 (dotted bar) DARPins per AcrBwt and AcrB_V612F variant, respectively. Errors
are calculated as standard error of the mean (SEM). Unpaired t-test resulted in a p value
of 0.022, thus imply a signiﬁcant difference of relative amount of DARPins bound to
AcrB wt and AcrB_V612F.co-crystal structure, 10 molecules of dodecyl-β-D-maltoside and 1
molecule of dodecyl-α-D-maltoside bound to the trimer are reported
[9]. The spectral shift is observedon theAcrBmonomers, suggesting that
binding of the molecule(s) representing this 3.1 kDa mass is much
stronger than the already strong binding of the individual monomers
constituting the AcrB trimer. Although a sum of 6 molecules of DDM
permonomerwould account for the observedmass, the observed “all or
nothing” shift of 3.1 kDa mass on the monomer peaks would represent
similar afﬁnities for all six DDM molecules to AcrB, which appears
unlikely. Moreover, the binding of molecule(s) representing thisFig. 7. Sedimentation velocity experiments with AcrB_V612F with and without bound
DARPins after SEC. The calculated mass difference between AcrB_V612F trimers with
(dotted line, 426.6±1.9 kDa) and without DARPins (solid line, 373.1±1.7 kDa)
corresponds to the mass of three DARPin molecules.
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detergent micelle, which occurs at very low laser intensities and
before the release of AcrB monomers from the trimeric assembly. The
unsatisfactory explanation concerning the identity of the 3.1 kDa
spectral shift triggered the analysis of the presence of phospholipids
in our AcrB samples. During the puriﬁcation process, AcrB is gradually
removed from thebacterialmembrane and its hydrophobic domains are
integrated into detergent/lipidmicelles. Phospholipids originating from
bacterial membranes have often been reported to be co-puriﬁed with
integral membrane proteins [33,34].
We initiated thin-layer chromatography (TLC) analysis with
puriﬁed samples of AcrB wt and AcrB_V612F to qualitatively identify
lipids which might have been co-puriﬁed. A number of phospholipid
standards, phospholipid mixtures, DDM solution and sample buffer
were run in parallel to the protein samples. The chromatography
plates then were stained by iodine (Fig. 8) and molybdatophosphoric
acid solution (not shown). The chromatography pattern of the two
protein samples (AcrB wt and AcrB_V612F) were basically identical
(Fig. 8, lanes 8 and 9). Two distinct spots are visible that may
represent phospholipids. The signal with the lower retention factor
corresponds with the migration pattern of DDM or cardiolipin, the
latter being an E. coli lipid component. The high retention factor signal
observed in the lanes containing protein samples (Fig. 8, lanes 8 and
9) may represent phosphatidylethanolamine (PE), commensurate to
the samples in lane 1 (polar lipid extract of E. coli) and lane 4
(dioleoyl-phosphatidylethanolamine, DOPE). Considering the mass of
each of the potential ligands which could give rise to the signal,
several combinations of each of the detected molecules could explain
the spectral shift of 3.1 kDa e.g. 6 molecules of DDM (Mw 511 Da), or a
combination of cardiolipin (1435.9 Da), PE (743.5 Da) and DDM. The
exact combination and ligand identities remain, however, elusive.4. Conclusions
We analyzed three different AcrB variants in detergent-solubilized
and crystalline state, with and without bound DARPin molecules. The
AcrB/DARPin complex stoichiometry differs depending on the AcrB
variant used, consistent with preliminary crystallographic data on
AcrB variant/DARPin co-crystals. Moreover, AcrB trimerization is due
to strong binding of the monomers, most likely via the periplasmic
loop (amino acids 218–239) protruding from one AcrB monomer into
the neighboring monomer. DARPin binding appears to be even
stronger than the interaction between the AcrB monomers, sinceFig. 8. Identiﬁcation of phospholipids by thin-layer chromatography (TLC) in puriﬁed
AcrB samples. E. coli polar lipids (lane 1), DOPC (lane 2), DOPA (lane 3), DOPE (lane 4),
cardiolipin (lane 5), 1% DDM (lane 6), sample buffer (lane 7), AcrB wt (lane 8) and
AcrB_V612F (lane 9). Samples were dissolved in buffers as described in Materials and
methods. TLC was performed using the eluent system CHCl3/MeOH/H2O (65:25:4, v/v).
The TLC plates were stained with iodine to visualize the lipid and detergent
components.interaction of DARPins is observed to trimeric, dimeric and mono-
meric AcrB. We also observed the consistent release of a 3.1 kDa mass
after high intensity laser exposure, whichmight represent very strong
binding of detergent and/or lipids.
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